Companies · Other Health Care

Aptiv Solutions, Inc.

RESTON · Other Health Care

Diligence memoA one-page analyst read on Aptiv Solutions, Inc. — recommendation, valuation, rhythm, risks.
$5.7M
Total raised · real
1
Rounds
Latest step-up
Top 34%
Sector rank · raised
Series A
Latest stage · inferred · Fri Apr 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Aptiv Solutions, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.98× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
  • Within the normal band (98% of peer median) for its niche.
Dormant
  • Last raise 14.2 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Aptiv Solutions, Inc. is one of 5376 Other Health Care companies tracked from RESTON. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2012-04-13 Raised $5.7M (real) Modeled valuation $114M (est)$5.7M$114MSeries A2012

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.7M · 2012

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$114.2M
Base estimate est.
$7.3M
Conservative case
$621.0M
Upside case
$25.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
14.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
14.2 yr
On record since
2012
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.3× above median
This company$5.7M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.0× above median
This company$5.7M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 5.2× above median
This company$114.2M
Sector median$22.1M

Raised more than 67% of sector peers (real $). Modeled value above 81% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #102 of 199.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)Aptiv Solutions, Inc. (this company) Raised $5.7M · modeled $114.2M (est)Aptiv Solutions, Inc.
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
Aptiv Solutions, Inc. this companySeries A$5.7M$114.2M0.98×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.7M2012-04-13$25.7M$114.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.7M2012-04-13
    • First recorded raise — entered as Series A.
Intelligence
Modeled next raise
$9.1M
Modeled next size est.range $5.9M$14.5M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David W. Dupree1 other2012-04
Patrick K. Donnelly1 other2012-04
Darren K. Black2012-04
Ian W. Lennox2012-04
J. Matthew Bond2012-04
Michael S. Falk2012-04
Registry & provenance

Aptiv Solutions, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1193940
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Rediscovery Life Sciences AKI LLCOther Health CareSeed$5.0M$3.4Mnetwork1 shared operator · same sector
Mid Holdings, LlcOther Health CareSeries A$5.6M$113.5Msame sector · same stage
Acuity EyeCare Rollover, LLCOther Health CareSeries A$5.7M$115.0Msame sector · same stage
Bootstrap Venture Fund L.P.Other Health CareSeries A$5.6M$113.3Msame sector · same stage
Silverado Senior Living, Inc.Other Health CareSeries A$5.6M$113.1Msame sector · same stage
PrismHealthDX, Inc.Other Health CareSeries A$5.6M$113.0Msame sector · same stage
Confluence Life Sciences, Inc.Other Health CareSeries A$5.7M$97.5Msame sector · same stage
Synagile CorpOther Health CareSeries A$5.6M$94.4Msame sector · same stage
Frequently asked
How much funding has Aptiv Solutions, Inc. raised?
Aptiv Solutions, Inc. has raised approximately $5.7M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Aptiv Solutions, Inc.'s estimated valuation?
Provath's modeled valuation for Aptiv Solutions, Inc. is approximately $114.2M (modeled range $7.3M–$621.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Aptiv Solutions, Inc. at?
Aptiv Solutions, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Apr 13.
What does Aptiv Solutions, Inc. do and where is it based?
Aptiv Solutions, Inc. operates in the Other Health Care sector, based in RESTON.
Explore related

See where Aptiv Solutions, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Aptiv Solutions, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.